| Marc F. Pelletier |
Marc F. Pelletier founded Iridia, Inc. in 2015, where he worked as Secretary & Director from 2017 to 2019, Aeromics, Inc. in 2008, where he worked as Chief Executive & Scientific Officer, and Gardiner Founder LLC in 2020, where he is working as Member from 2020. Dr. Pelletier also currently works at Gardiner Healthcare Acquisitions Corp., as Chairman & Chief Executive Officer from 2021. Dr. Pelletier received his doctorate degree from McGill University and undergraduate degree and graduate degree from Concordia University. |
| Frank C. Sciavolino |
Frank C. Sciavolino is the founder of Thetis Pharmaceuticals LLC, which was founded in 2011, where he holds the position of President, Director & Chief Scientific Officer. Dr. Sciavolino is also the founder of Gardiner Founder LLC. Currently, he is an Independent Director at Gardiner Healthcare Acquisitions Corp. since 2021. In the past, he worked as a Director-Research & Development at Pfizer Inc. from 1968 to 2003. He also worked as an Executive Vice President-Development at Indigene Pharmaceuticals Pvt Ltd. and as an Executive VP-Global Design & Development at Indigene Pharmaceuticals, Inc. from 2003 to 2010. Additionally, he held the position of Principal at Pfizer (St. Louis). Dr. Sciavolino completed his undergraduate degree at St. John's University and his doctorate at the University of Michigan. |
| James P. Linton |
James P. Linton founded Iridia, Inc. in 2016, where he worked as President & Director from 2017 to 2019 and New Frontier Bio, Inc. in 2020, where he is working as Director from 2020. Dr. Linton also currently works at Resolute Bio, Inc., as Chief Executive Officer from 2021 and Gardiner Healthcare Acquisitions Corp., as Independent Director from 2021. Dr. Linton received his doctorate degree from Emory University and Masters Business Admin degree from the University of California, Davis. |
| Matthew Rossen |
Matthew Rossen is an Independent Director at Gardiner Healthcare Acquisitions Corp. and a Vice President-Marketing at Tarsus Pharmaceuticals, Inc. He was a Senior Director-Business Development at Jazz Pharmaceuticals, Inc. from 2010 to 2019 and a Senior Manager-Commercial Development at Pfizer Inc. from 2001 to 2010. He was also an Independent Director at Chardan Healthcare Acquisition Corp. from 2018 to 2019 and an Independent Director at Chardan Healthcare Acquisition 2 Corp. He holds an undergraduate degree from The University of Colorado and an MBA degree from The Leonard N Stern School of Business. |
| Thomas F. Ryan |
Thomas F. Ryan is currently the Chief Executive Officer at Navigator Bio LLC and an Independent Director at Gardiner Healthcare Acquisitions Corp. Previously, he worked as the Director of Business Development at Eurofins Central Laboratory LLC from 2014 to 2017 and as the Manager of Strategic Account at Lantheus Medical Imaging, Inc. from 2011 to 2014. |
